Velmanase alfa
Lamzede (velmanase alfa) is an enzyme pharmaceutical. Velmanase alfa was first approved as Lamzede on 2018-03-23. It has been approved in Europe to treat alpha-mannosidosis.
| Trade Name | Lamzede |
|---|---|
| Common Name | Velmanase alfa |
| Indication | alpha-mannosidosis |
| Drug Class | Enzymes |
